Skip to main content
ACLSAxcelis Technologies, Inc.Sell5.8·$113.64
SellModerate Confidence
Investment thesis

Axcelis has delivered four consecutive earnings beats averaging roughly 29%, but the stock has moved above its near-term price target with negative headroom remaining, and an extreme put/call ratio above 5-to-1 reflects substantial bearish options positioning that elevates near-term downside risk.

Thesis pillars

  • Geographic Concentration Asia→Stable
  • Price Above Target No Upside↓Deteriorating
  • Extreme Bearish Options Positioning→Stable
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 26, 2026

Full reasoning →

Open full analysis

Axcelis Technologies, Inc. (ACLS) Stock Analysis

SellGrowthModerate Confidence

Technology · Semiconductor Equipment & Materials

Earnings in 7 days (2026-11-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. At $113.64, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%).

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current... Read more

$113.64+12.2% A.UpsideScore 5.8/10#14 of 24 Semiconductor Equipment & Materials
QualityF-score8 / 9FCF yield1.20%
Stop $105.69Analyst target $127.50(−15% haircut)A.R:R 1.0:1
Analyst consensus$150.00+32.0%3 analysts
$127.50Analyst target
$113.64price
$150.00mean
$165

Sell if holding. At $113.64, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.8/10, moderate confidence.

Passes 3/7 gates (clean insider activity, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 7d<=7d. Suitability: speculative.

10-K grounded · weekly refresh

About Axcelis Technologies, Inc.

About Axcelis Technologies, Inc.

Axcelis Technologies manufactures ion implant systems for semiconductor chip manufacturers, with international sales representing 83.7% of total revenue in 2025 and Asia-based system shipments accounting for 76.0% of total system revenue the same year. The top ten customers comprised 55.2% of net sales in 2025, and individual system prices range from approximately $2.6 million to $12.0 million. A recurring aftermarket stream of parts, consumables, upgrades, and service contracts supplements new system sales.

Axcelis earns revenue through two primary streams: new ion implant system sales to semiconductor chip manufacturers and an aftermarket business comprising parts, consumables, upgrades, service contracts, and time-and-materials billings. The aftermarket historically provides a significant portion of product revenue and all service revenue, offering partial insulation from cyclical swings in new equipment orders. System purchases depend entirely on semiconductor manufacturers' capital expenditure decisions, creating lumpy quarterly revenue where individual systems can materially shift a period's results. Component manufacturing relies on a limited group of outside vendors who produce subassemblies through complex processes with long lead times, limiting the company's ability to substitute on short notice. Competition includes one company with substantially greater financial and engineering resources, plus smaller non-U.S. rivals including Advanced Ion Beam Technology, Inc., Nissin Ion Equipment Co., Ltd., and Sumitomo Heavy Industries Ion Technology Co., Ltd., all of which may benefit from U.S.-China trade restrictions pushing Chinese customers toward non-American vendors.

Show full overview

China-related export control risk represents the most identifiable regulatory exposure: SMIC was placed on the U.S. Entity List in 2020, requiring Axcelis to obtain export licenses for shipments to SMIC fabs, and the October 2022 BIS framework prohibits all semiconductor equipment exports to Chinese customers producing or developing advanced logic, DRAM, and NAND chips meeting specific parameters. The 10-K states that "continuing revenue from Chinese customers is at higher risk than continuing revenue from customers in other international locations." Two domestic Chinese companies — Kingstone Semiconductor and CETC Electronics Equipment Group Co., Ltd. — continue developing local ion implanters, raising the prospect of permanent Chinese market share erosion regardless of broader trade policy shifts. In March 2026, the company disclosed via Form 8-K the departure of CFO James Coogan, with an internal appointment of an Interim CFO underway.

See also: Technology · Semiconductor Equipment & Materials

From Axcelis Technologies, Inc.'s most recent 10-K filing, extracted June 9, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 5, 20267d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Strong growth profile
Risks
Concentration risk — Geographic: international sales (83.7%)
Concentration risk — Geographic: Asia (76.0%)
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.2)

Key Metrics

P/E (TTM)38.1
P/E (Fwd)21.6
Mkt Cap$3.5B
EV/EBITDA32.0
Profit Mgn10.7%
ROE8.9%
Rev Growth10.6%
Beta1.85
DividendNone
Rating analysts10

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.65bearish
IV83%elevated

Concentration Risks(10-K Item 1A)

  • HIGHGeographicinternational sales84%
    10-K Item 1A: 'International sales...accounted for 83.7% of total revenue in 2025'
  • HIGHGeographicAsia76%
    10-K Item 1A: 'Ion implanter system shipments to customers in Asia represented 76.0% of total system revenue in 2025'
  • HIGHCustomertop ten customers55%
    10-K Item 1A: 'our top ten customers accounted for 55.2% of our net sales'
  • MEDIUMSupplierlimited group of suppliers
    10-K Item 1A: 'We obtain many of these components and sub-assemblies from a limited group of suppliers'

Material Events(8-K, last 90d)

  • 2026-03-12Item 5.02MEDIUM
    CFO James Coogan notified Axcelis of resignation effective April 24, 2026; no disagreement cited. Board appointed David Ryzhik (SVP of Investor Relations and Corporate Strategy since July 2024) as Interim CFO effective March 12, 2026.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.0<4.5A.R:R 1.0 < 1.5@spotEARNINGS PROXIMITY 7d<=7dExecutive change: officer departure/appointmentInsider activity: OKSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Speculative
RSI
30 · Oversold
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $104.00Resistance $149.95

Price Targets

$106
$128
A.Upside+12.2%
A.R:R1.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! momentum at 4.0 (below the engine's 4.5 threshold)
! asymmetry at 1.0 (below the engine's 1.5 threshold)@spot
! EARNINGS_PROXIMITY:7d<=7d

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-11-05 (7d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ACLS stock a buy right now?

Sell if holding. At $113.64, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $105.69. Score 5.8/10, moderate confidence.

What is the ACLS stock price target?

Analyst target: $127.50 (+12.2% upside). Prior stop was $105.69. Stop-loss: $105.69.

What are the risks of investing in ACLS?

Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.2).

Is ACLS overvalued or undervalued?

Axcelis Technologies, Inc. trades at a P/E of 38.1 (forward 21.6). TrendMatrix value score: 5.8/10. Verdict: Sell.

What do analysts say about ACLS?

10 analysts cover ACLS with a consensus score of 2.5/5. Average price target: $150.

What does Axcelis Technologies, Inc. do?Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in...

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force. Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.

Related stocks: KLIC (Kulicke and Soffa Industries, I) · ACMR (ACM Research, Inc.) · FORM (FormFactor, Inc.) · AMKR (Amkor Technology, Inc.) · ONTO (Onto Innovation Inc.)
Home › Stocks › ACLS

Latest news

Latest News

Yahoo Finance28d ago
Dars.gov.et91d ago
MarketBeat91d ago
TradingKey91d ago
Kalkine Media91d ago
ABC11 Raleigh-Durham182d ago
TipRanks182d ago
GuruFocus63d ago
Today FM 95.163d ago
GuruFocus77d ago
Kalkine Media84d ago
GuruFocus29d ago
Simplywall.st92d ago
Yahoo Finance92d agoProduct
TradingKey92d ago
Education Week183d ago
PR Newswire183d ago
MSN183d ago
Yahoo Finance64d ago
Yahoo Finance36d ago
Loading more...